- Romiplostim, sold
under the
brand name
Nplate among others, is a
fusion protein analog of thrombopoietin, a
hormone that
regulates platelet production...
- cancer.
Vectibix was
approved by the FDA in
September 2006. 2008: In August,
Nplate (romiplostim) was
approved by the FDA. 2010: On June 6, 2010,
Amgen received...
-
endogenous thrombopoietin or lead to thrombosis.
Romiplostim (trade name
Nplate,
formerly AMG 531) was
found to be safe and
effective for the treatment...
- destruction. Two such
products are
currently available:
Romiplostim (trade name
Nplate) is a
thrombopoiesis stimulating Fc-peptide
fusion protein (peptibody) that...
- include:
Amevive (alefacept),
Arcalyst (rilonacept),
Enbrel (etanercept),
Nplate (romiplostim),
Orencia (abatacept) and
Nulojix (belatacept).
Enbrel (etanercept)...
-
Retrieved 2007-05-15. Waknine, Yael (September 4, 2008). "FDA Approvals:
Nplate, Aloxi, Vidaza". Medscape.
Archived from the
original on
December 2, 2008...
- PMC 1618755. PMID 17106506.
Waknine Y (September 4, 2008). "FDA Approvals:
Nplate, Aloxi, Vidaza". Medscape.
Archived from the
original on 2008-12-02. Retrieved...
-
contributed significantly to the
development of Amifostine, Neupogen, Neulasta,
Nplate, and Leukine, a
series of
drugs treating or
preventing radiation injuries...
